Sinopharm Group Co. Ltd. Announces Date for Extraordinary General Meeting

Reuters12-04
<a href="https://laohu8.com/S/SHTDF">Sinopharm Group Co. Ltd.</a> Announces Date for Extraordinary General Meeting

Sinopharm Group Co. Ltd. will hold an extraordinary general meeting on December 19, 2025, at its Sinopharm Group Building in Shanghai, China. During the meeting, shareholders will consider and vote on the appointment of Mr. Jin Bin as a non-executive Director of the sixth session of the Board, with authorization for the Board to determine his remuneration and for the Chairman or any executive Director to enter into a service contract or related agreements with him. Additionally, the appointment of Ms. Li Ying as a non-executive Director of the sixth session of the Board will be considered, along with similar authorization for the Board regarding her remuneration and service contract arrangements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinopharm Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251204-11942996), on December 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment